Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma

Clinical trial NCT01106235 · TERMINATED

Trial details

NCT number: NCT01106235
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 2010-04-01
Primary completion: 2011-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.